semaglutide supply news november 2025 Yearslong shortage of popular weight-loss and diabetes drugs is resolved, FDA says GoodRx to Match Novo Nordisk

[DOI] [PubMed] [Google Scholar] 25.Chan K, Lu R, Chang JC, Kan YW

To help people better understand their HbA1C lab results, the ADA recommends the use of estimated average glucose (eAG) because it is expressed in the same units as home glucose readings (mg/dL)

What they do is help the liver process fat cells that have already been broken down by the body, they do not break down fat cells themselves

Glycine serves as a stabilizer in the formulation, while B12 supplementation helps address potential deficiencies that can occur with reduced food intake during GLP-1 treatment

The market is diversifying beyond weekly injectables into new delivery formsincluding orals (both peptide and small-molecule) and combo regimens

More Studies Are Needed Semaglutide is a relatively new medication for weight loss, though it has been used for diabetes treatment for a longer time